Management to Hold Conference Call at 8:30 a.m. EDT
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2025 on Thursday, August 14, 2025, before the U.S. markets open.
https://mma.prnewswire.com/media/2154863/BioLineRx_Ltd_Logo.jpg
The Company will host a conference call at 8:30 a.m. EDT featuring remarks by Philip Serlin, Chief Executive Officer.
To access the conference call, please dial +1-888-281-1167 from the U.S. or +972-3-918-0685 internationally. A live webcast and a replay of the call can be accessed through the event page on the Company's website. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast. The call replay will be available approximately two hours after completion of the live conference call. A dial-in replay of the call will be available until August 16, 2025; please dial +1-888-295-2634 from the US or +972-3-925-5904 internationally.
About BioLineRx
BioLineRx Ltd. (NASDAQ/TASE: BLRX) is a biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. The Company's first approved product is APHEXDA® (motixafortide), with an indication in the U.S. for stem cell mobilization forautologous transplantation in multiple myeloma, which is being developed and commercialized by Ayrmid Ltd. (globally, excluding Asia) and Gloria Biosciences (in Asia). BioLineRx is utilizing its end-to-end expertise in development, regulatory affairs, manufacturing and commercialization to advance its innovative pipeline and ensure life-changing discoveries move beyond the bench to the bedside.
Learn more about who we are, what we do, and how we do it atwww.biolinerx.com or onLinkedIn.
CONTACTS:United StatesIrina KofflerLifeSci Advisors, LLCIR@biolinerx.com
IsraelMoran MeirLifeSci Advisors, LLCmoran@lifesciadvisors.com
Logo: https://mma.prnewswire.com/media/2154863/BioLineRx_Ltd_Logo.jpg
https://c212.net/c/img/favicon.png?sn=IO46393&sd=2025-08-07
View original content:https://www.prnewswire.com/news-releases/biolinerx-to-report-second-quarter-2025-results-on-august-14-2025-302524198.html
SOURCE BioLineRx Ltd.
https://rt.newswire.ca/rt.gif?NewsItemId=IO46393&Transmission_Id=202508070700PR_NEWS_USPR_____IO46393&DateId=20250807